Docoh
Loading...

SGRY Surgery Partners

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The Company held its Annual Meeting on May 26, 2021. As of the close of business on April 8, 2021, the record date for the Annual Meeting (the “Record Date”), 59,890,985 shares of the Company’s common stock were outstanding and entitled to vote. In addition, as of the Record Date, there were 310,000 shares of the Company's 10.00% Series A Convertible Perpetual Participating Preferred Stock (the “preferred stock”) issued and outstanding, entitling the holders of preferred stock the right to cast 22,371,576 votes on an as-converted basis. At the Annual Meeting, shares of the Company’s common stock and preferred stock voted together as a single class on the matters described below.

The matters voted on at the Annual Meeting and the final results of such voting were as follows:

Proposal 1: Election of Class III director nominees. The stockholders elected each of the director nominees to serve as a Class III director until the Company’s 2024 annual meeting of stockholders and until each such successor has been elected and qualified. Each of the nominees, with the exception of Blair E. Hendrix, was a current Class III director of the Company who was re-elected. The results of the vote were as follows:

NameVotes ForVotes WithheldBroker Non-Votes
Clifford G. Adlerz67,880,6039,437,8461,713,555
J. Eric Evans69,344,3147,974,1351,713,555
Blair E. Hendrix66,493,68310,824,7661,713,555
Andrew T. Kaplan65,829,67911,488,7701,713,555


Proposal 2: Advisory vote on executive compensation (“Say-on-Pay”). The stockholders approved on a non-binding, advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 15, 2021. The results of the vote were as follows:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
76,699,550591,43527,4641,713,555


Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered accounting firm for fiscal 2021. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the vote were as follows:

Votes ForVotes AgainstAbstentions
78,984,67440,6816,649


Proposal 4: Approval of the Amendment to the Omnibus Incentive Plan. The stockholders approved the Amendment to the Omnibus Incentive Plan. The results of the vote were as follows:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
63,084,36413,563,113670,9721,713,555